Correlation Between Ultragenyx and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Ultragenyx and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Apellis Pharmaceuticals.
Diversification Opportunities for Ultragenyx and Apellis Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ultragenyx and Apellis is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Ultragenyx i.e., Ultragenyx and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ultragenyx and Apellis Pharmaceuticals
Given the investment horizon of 90 days Ultragenyx is expected to generate 0.66 times more return on investment than Apellis Pharmaceuticals. However, Ultragenyx is 1.52 times less risky than Apellis Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 4,207 in Ultragenyx on November 1, 2024 and sell it today you would earn a total of 40.00 from holding Ultragenyx or generate 0.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultragenyx vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Ultragenyx |
| Apellis Pharmaceuticals |
Ultragenyx and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultragenyx and Apellis Pharmaceuticals
The main advantage of trading using opposite Ultragenyx and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |